{"DataElement":{"publicId":"2528319","version":"1","preferredName":"Malignant Neoplasm Allogeneic Hematopoietic Stem Cell Transplantation Best Response Date","preferredDefinition":"the date of the best improvement related allogeneic hematopoietic stem cell transplantation, a clinical treatment in which stem cells capable of reconstituting the immune system and blood production (hematopoiesis) are transferred from one genetically dissimilar individual to another, for a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"TUM_HSCT_B_RES_DT","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2528311","version":"1","preferredName":"Malignant Neoplasm Allogeneic Hematopoietic Stem Cell Transplantation Best Response","preferredDefinition":"information related to the best improvement related allogeneic hematopoietic stem cell transplantation, a clinical treatment in which stem cells capable of reconstituting the immune system and blood production (hematopoiesis) are transferred from one genetically dissimilar individual to another, for a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"TUM_HSCT_B_RESP","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2528309","version":"1","preferredName":"Allogeneic Hematopoietic Stem Cell Transplantation Best Response","preferredDefinition":"A clinical treatment in which HSC capable of reconstituting the immune system and blood production (hematopoiesis) are transferred from one genetically dissimilar individual to another. The donor and recipient may or may not be related. 2005:Having the most positive qualities.:In medicine, an improvement related to treatment.","longName":"C46089:C25432:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allogeneic Hematopoietic Stem Cell Transplantation","conceptCode":"C46089","definition":"A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20083020-DE55-4745-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-17","modifiedBy":"ONEDATA","dateModified":"2006-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20083020-DE66-4745-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018550","version":"1","preferredName":"Date","preferredDefinition":"The date on which an observation was made or an event occurred.","longName":"DT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"format":"MM/DD/YYYY","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B54EF112-5457-674A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-28","modifiedBy":"ZHWENDY","dateModified":"2023-12-12","changeDescription":"8/3/17 tt added Diagnosis CSI. 6/20/17 jk transferred to NCI Standards per confirmation by Brian Campbell as part of Round 5 finalization task, added reg status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"Date Achieved","type":"Preferred Question Text","description":"Date Achieved","url":null,"context":"NHLBI"},{"name":"ECOG CRF Text 1","type":"Alternate Question Text","description":"Date patient achieved PLT >=100k without transfusion","url":null,"context":"ECOG-ACRIN"}],"origin":"Transplant CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"200849BE-6B1E-4C8F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-17","modifiedBy":"KUMMEROA","dateModified":"2021-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}